Joan was diagnosed with early-stage Alzheimer’s disease. There was nothing doctors could do. But now, a recently FDA-approved ...

An advisory panel to the U.S. Food and Drug Administration on Wednesday voted resoundingly against recommending a stem ...

The panel of Food and Drug Administration experts voted 17-1 that drugmaker Brainstorm’s stem cell-based treatment has not ...

Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 JST Share Tweet list Print This image provided by Eisai in January 2023 shows vials and packaging for ...

The US FDA has issued proposal guidance to assist companies developing new treatments for patients in the early stages of Alzheimer’s disease, before the onset of noticeable (overt) dementia.

"FDA is the 800-pound gorilla here and if they're convinced that the drug doesn't work it's very hard to change their minds," ...

The FDA also gave full approval to a drug called Leqembi, which slowed Alzheimer’s patients’ functional and cognitive decline by 27% over 18 months, according to trial data.

We’ll send you a myFT Daily Digest email rounding up the latest Vivek Ramaswamy news every morning. US biotech company Roivant Sciences has moved to distance itself from its founder, Vivek ...

A medication that could help treat early stages of Alzheimer's disease is on track to be approved for manufacturing and sales in Japan after being endorsed by a health ministry expert panel on ...

TOKYO (AP) — Japan's health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by ...

Lecanemab, better known as Leqembi, is the first traditionally approved treatment to address the underlying biology of ...

More than 6,000,000 Americans are living with Alzheimer's disease – it slowly steals your memories and takes away your mind ...